Evidence-Based Medicine Guidelines
Meropenem vs imipenem plus cilastatin for severe infections
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Meropenem Vs Imipenem Plus Cilastatin for Severe Infections." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections.
Meropenem vs imipenem plus cilastatin for severe infections. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections. Accessed September 22, 2023.
Meropenem vs imipenem plus cilastatin for severe infections. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections
Meropenem Vs Imipenem Plus Cilastatin for Severe Infections [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 September 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Meropenem vs imipenem plus cilastatin for severe infections
ID - 451820
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
